Home investment philosophy Portfolio Team News Contact Us Investor Login

Cordant

 

Cordant Health Solutions™ is setting its sights on toxicology innovation. Its portfolio ranges from medication monitoring and criminal justice drug testing to pre-employment drug screening, addiction and treatment-center drug testing, workers' compensation case management, and reference lab solutions. As a reliable partner, Cordant provides testing protocols and digital case-management tools to help its customers become more efficient and effective. With its high-value services and intelligent solutions, Cordant strives to change the way its clients use toxicology results and to assist its clients in navigating the ever-changing landscapes in which they operate.

  Industry:
Toxicology services
  Headquarters:
Denver, Colorado
  Date of Investment:   
February 2012
  Fund:
WCP Fund III
  Website:
Areas of Acquisition Focus

  • Toxicology services, including CAP-FDT and SAMHSA testing
    • Supplemental case-management solutions
    • Specimen collection and third-party administrative services
    • Manufacturing and distribution of diagnostic products
Related News

 

“The partnership with Waud Capital has optimized Cordant’s execution of strategies to develop a national footprint of toxicology laboratories, align with payers, and develop patent-pending technologies and other strategic solutions aligned with our state-of-the-art laboratory testing. With Waud’s support we have expanded to serve four key markets across the country, and are growing every day. We enjoy a working partnership with Waud that goes beyond the capital they have provided to Cordant.”



Susan Sommer
President and Chief Executive Officer

 

 
 
Home | About Us | Portfolio | News | Investor Access | Contact Us | Map/Directions | Printable Materials | Regulatory Information